Showing 1551-1560 of 3281 results for "".
Nonverbal Communication in the Patient Consultation
https://practicaldermatology.com/topics/practice-management/1109_07-php/22059/Recognition of the most common body language cues can help you understand what your patients may be thinking but not saying out loud.Reviving the Dream: Correcting Suboptimal Results from Injectable Treatments
https://practicaldermatology.com/topics/general-topics/PD0309_10-php/22864/Skill, patience and meticulous selection of products and injection techniques are pre-requisites for satisfactory correction of a poor outcome from treatment with dermal fillers and botulinum toxin.Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in aChallenges and Opportunities for the Dermatology Specialty
https://practicaldermatology.com/topics/practice-management/challenges-and-opportunities-for-the-dermatology-specialty/23881/Joining together may help address some of the issues facing board-certified dermatologists.Making Melanoma Diagnosis and Treatment More Predictable
https://practicaldermatology.com/topics/skin-cancer-photoprotection/making-melanoma-diagnosis-and-treatment-more-predictable/37102/Melanoma can be a very humbling disease. Some of the most talented doctors have been challenged over the years when diagnosing and planning treatment for melanoma because of its variability.How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivCase Report: First Reported Case of Facial Rash After Dupilumab Therapy; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-first-reported-case-of-facial-rash-after-dupilumab-therapy-call-for-abstracts/20499/Intergenerational Dermatologists: A Family Tradition in All Respects
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatologists-a-family-tradition-in-all-respects/23977/With Sandra Lee, MD, and Jeffrey Rebish, MD, By Heidi SpleteWhat If It’s Not Atopic Dermatitis?
https://practicaldermatology.com/topics/infections-infectious-disease/what-if-its-not-atopic-dermatitis/23812/A photo-assisted guide to differential diagnosis.Keratosis Pilaris: A Rough and Bumpy Review
https://practicaldermatology.com/columns/clinical-focus-1/keratosis-pilaris-a-rough-and-bumpy-review/23618/There are promising interventions for this challenging presentation.